Evoked potentials are of little use in the diagnosis or monitoring of MS: No

Abstract

Get full access to this article

View all access options for this article.

References

Confavreux

Vukusic

Moreau

. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430–1438.

Leocani

Rovaris

Boneschi

. Multimodal evoked potentials to assess the evolution of multiple sclerosis: A longitudinal study. J Neurol Neurosurg Psychiatry 2006; 77: 1030–1035.

Bejarano

Bianco

Gonzalez-Moron

. Computational classifiers for predicting the short-term course of Multiple Sclerosis. BMC Neurology 2011; 11: 67. DOI: 10.1186/1471-2377-11-67.

Jung

Beyerle

Ziemann

. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis. Mult Scler 2008; 14: 553–556.

Kallmann

Fackelmann

Toyka

. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler 2006; 12: 58–65.

Schlaeger

D’Souza

Schindler

. Combined evoked potentials as markers and predictors of disability in early multiple sclerosis. Clin Neurophysiol 2012; 123: 406–410.

Fernandez

Postigo

Urbaneja

. Comparing objective measures of neurodegeneration in multiple sclerosis (MS). Twenty-third Meeting of the European Neurological Society, 8–11 June, 2013 Barcelona, Spain. J Neurol 2013; 260 (Suppl 1): S229.

Connick

Kolappan

Crawley

. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurol 2012; 11: 150–156.